PHARMACOLOGICAL CHARACTERIZATION OF RP-62203, A NOVEL 5-HYDROXYTRYPTAMINE 5-HT2 RECEPTOR ANTAGONIST

被引:44
作者
DOBLE, A
GIRDLESTONE, D
PIOT, O
ALLAM, D
BETSCHART, J
BOIREAU, A
DUPUY, A
GUEREMY, C
MENAGER, J
ZUNDEL, JL
BLANCHARD, JC
机构
[1] Rhǒne‐Poulenc Rorer, Centre de Recherche de Vitry-Alfortville, Vitry-Sur-Seine
关键词
5-HYDROXYTRYPTAMINE; 5-HT2 RECEPTOR ANTAGONISTS; RP-62203; BINDING; INOSITOL PHOSPHATE; RAPHE; NEURONAL ACTIVITY; HEAD-TWITCH;
D O I
10.1111/j.1476-5381.1992.tb14206.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 RP 62203 (2-[3-(4-(4-fluorophenyl)-piperazinyl)propyl]naphto[1,8-ca]isothiazole-1,1-dioxide) is a novel naphtosultam derivative which shows very high affinity for 5-HT2 receptors in the rat cerebral cortex (K(i) = 50.0 pM). 2 RP 62203 is relatively selective for this sub-type of 5-hydroxytryptamine (5-HT) receptor, having lower affinity for the 5-HT1A receptor and very low affinity for the 5-HT3 receptor. RP 62203 displayed low to moderate affinity for alpha(1)-adrenoceptors, dopamine D2 receptors and histamine H-1 receptors. 3 In vivo binding experiments demonstrated that oral administration of low doses of RP 62203 led to a long-lasting (> 6 h) occupation of cortical 5-HT2 receptors (ID50 = 0.39 mg kg-1). 4 In cortical slices from the neonatal rat, RP 62203 potently inhibited inositol phosphate formation evoked by 5-HT, with an IC50 of 7.76 nM. 5 The activity of neurones in the raphe and their responses to microiontophoretically applied 5-HT were studied with extracellular recording electrodes in the anaesthetized rat. RP 62203 potently and dose-dependently blocked excitations evoked by 5-HT when administered at doses of 0.5-4.0 mg kg-1, i.p. In contrast, neither 5-HT-evoked depressions nor glutamate-evoked excitations of raphe neuronal firing were blocked by RP 62203 at doses as high as 8.0 mg kg-1, i.p. 6 Head twitches induced by 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) could be abolished by low doses of RP 62203 in mice (ED50 = 0.44 mg kg-1, p.o.) and in rats (ED50 = 1.54 p.o.). Similar results were obtained with mescaline and 5-hydroxytryptophan (5-HTP). 7 The potency of RP 62203 was compared with that of three other 5-HT2 receptor antagonists, ritanserin, ICI 169,369 and ICI 170,809. In all models, RP 62203 showed similar activity to ritanserin, whilst either ICI 169,369 or ICI 170,809 was several fold less active. 8 It is concluded that RP 62203 is a potent and selective antagonist at 5-HT2 receptors in the rodent central nervous system.
引用
收藏
页码:27 / 36
页数:10
相关论文
共 69 条
[1]   SEROTONIN-INDUCED INWARD CURRENT IN RAT FACIAL MOTONEURONS - EVIDENCE FOR MEDIATION BY G-PROTEINS BUT NOT PROTEIN-KINASE-C [J].
AGHAJANIAN, GK .
BRAIN RESEARCH, 1990, 524 (01) :171-174
[2]   PHARMACOLOGICALLY DISTINCT ACTIONS OF SEROTONIN ON SINGLE PYRAMIDAL NEURONS OF THE RAT HIPPOCAMPUS RECORDED INVITRO [J].
ANDRADE, R ;
NICOLL, RA .
JOURNAL OF PHYSIOLOGY-LONDON, 1987, 394 :99-124
[3]   LITHIUM AMPLIFIES AGONIST-DEPENDENT PHOSPHATIDYLINOSITOL RESPONSES IN BRAIN AND SALIVARY-GLANDS [J].
BERRIDGE, MJ ;
DOWNES, CP ;
HANLEY, MR .
BIOCHEMICAL JOURNAL, 1982, 206 (03) :587-595
[4]   PHARMACOLOGICAL STUDIES INVIVO WITH ICI-169,369, A CHEMICALLY NOVEL 5-HT2/5-HT1C RECEPTOR ANTAGONIST [J].
BLACKBURN, TP ;
COX, B ;
THORNBER, CW ;
PEARCE, RJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 180 (2-3) :229-237
[5]   INVITRO STUDIES WITH ICI-169,369, A CHEMICALLY NOVEL 5-HT ANTAGONIST [J].
BLACKBURN, TP ;
THORNBER, CW ;
PEARCE, RJ ;
COX, B .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 150 (03) :247-256
[6]  
BLACKBURN TP, 1988, FASEB J, V2, pA1404
[7]   PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE [J].
BRADLEY, PB ;
ENGEL, G ;
FENIUK, W ;
FOZARD, JR ;
HUMPHREY, PPA ;
MIDDLEMISS, DN ;
MYLECHARANE, EJ ;
RICHARDSON, BP ;
SAXENA, PR .
NEUROPHARMACOLOGY, 1986, 25 (06) :563-576
[8]   INOSITOL PHOSPHOLIPID HYDROLYSIS IN RAT CEREBRAL CORTICAL SLICES .1. RECEPTOR CHARACTERIZATION [J].
BROWN, E ;
KENDALL, DA ;
NAHORSKI, SR .
JOURNAL OF NEUROCHEMISTRY, 1984, 42 (05) :1379-1387
[9]  
BYLUND DB, 1976, MOL PHARMACOL, V12, P568
[10]   BINDING OF TYPICAL AND ATYPICAL ANTIPSYCHOTICS TO 5-HT1C AND 5-HT2 SITES - CLOZAPINE POTENTLY INTERACTS WITH 5-HT1C SITES [J].
CANTON, H ;
VERRIELE, L ;
COLPAERT, FC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 191 (01) :93-96